⌘K

Home/Filings/5/0001104659-23-018593

5//SEC Filing

DAWES KAREN A 5

Accession 0001104659-23-018593

CIK 0001828185other

View on SEC.gov Company Profile

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 4:34 PM ET

Size

5.8 KB

Accession

0001104659-23-018593

Insider Transaction Report

Form 5

Period: 2022-12-31

Vaccitech plcVACC

Director

Transactions

Award
Share Option (Right to Buy)
2022-06-15+18,604→ 18,604 total
Exercise: $4.27Exp: 2032-06-15→ Ordinary Shares (18,604 underlying)

Footnotes (2)

[F1]One-third of the shares underlying this option shall vest and become exercisable on June 15, 2023, with the remainder vesting in 24 equal monthly installments thereafter.
[F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file

5
tm236344-1_5seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Vaccitech plc

CIK 0001828185

Entity typeother

Related Parties

1

filerCIK 0001261506

Filing Metadata

Form type: 5
Filed: Feb 9, 7:00 PM ET
Accepted: Feb 10, 4:34 PM ET
Size: 5.8 KB

View on SEC.gov